Safety and Tolerability Study of Aptiganel Hydrochloride in Patients With an Acute Ischemic Stroke
- 1 October 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 30 (10) , 2038-2042
- https://doi.org/10.1161/01.str.30.10.2038
Abstract
Background and Purpose—Aptiganel (CNS 1102) is a selective, noncompetitive antagonist that acts on the ion channel associated with the N-methyl-d-aspartate (NMDA) receptor and is neuroprotective in...Keywords
This publication has 9 references indexed in Scilit:
- Effects of Prolonged Infusions of the NMDA Antagonist Aptiganel Hydrochloride (CNS 1102) in Normal VolunteersClinical Neuropharmacology, 1997
- The Effects of Lifarizine in Acute Cerebral Infarction: A Pilot Safety StudyCerebrovascular Diseases, 1996
- White matter changes and ventricular enlargement on magnetic resonance imaging: Comparison between normal elderly subjects and patients with cerebrovascular disordersJournal Of Stroke & Cerebrovascular Diseases, 1994
- Effects of a novel NMDA receptor antagonist on experimental stroke quantitatively assessed by spectral EEG and infarct volumeNeurological Research, 1994
- Pharmacological effects of the non‐competitive NMDA antagonist CNS 1102 in normal volunteers.British Journal of Clinical Pharmacology, 1994
- Intravenous Nimodipine West European Stroke Trial (INWEST) of Nimodipine in the Treatment of Acute Ischaemic StrokeCerebrovascular Diseases, 1994
- Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion‐weighted MRINeurology, 1993
- Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man.British Journal of Clinical Pharmacology, 1992